Ilkay S Idilman
Overview
Explore the profile of Ilkay S Idilman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Narayanasamy S, Franca M, Idilman I, Yin M, Venkatesh S
Gut Liver
. 2025 Jan;
19(1):31-42.
PMID: 39774121
Imaging plays a critical role in the management of chronic liver disease (CLD) because it is a safe and painless method to assess liver health. The widely used imaging techniques...
3.
4.
Venkatesh S, Harper K, Borhani A, Furlan A, Thompson S, Chen E, et al.
Radiographics
. 2024 Aug;
44(9):e240006.
PMID: 39146204
Hepatic sinusoids are highly specialized microcirculatory conduits within the hepatic lobules that facilitate liver functions. The sinusoids can be affected by various disorders, including sinusoidal dilatation, sinusoidal obstruction syndrome (SOS),...
5.
Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome
Eroglu B, Karacoban L, Idilman I, Korkusuz F, Yildiz B
Maturitas
. 2024 Apr;
185:107982.
PMID: 38579578
Objective: The potential effects of polycystic ovary syndrome (PCOS) on the musculoskeletal system are not well established. We examined the musculoskeletal system in women with PCOS in their late reproductive...
6.
Eroglu I, Iremli B, Erkoc A, Idilman I, Yuce D, Calik Kutukcu E, et al.
J Clin Densitom
. 2024 Mar;
27(2):101479.
PMID: 38447349
Objective: Hyperprolactinemia has negative impacts on metabolism and musculoskeletal health. In this study, individuals with active prolactinoma were evaluated for nonalcoholic fatty liver disease (NAFLD) and musculoskeletal health, which are...
7.
Venkatesh S, Idilman I, Li J, Yin M
Hepatobiliary Surg Nutr
. 2024 Feb;
13(1):132-135.
PMID: 38322227
No abstract available.
8.
Qadri S, Vartiainen E, Lahelma M, Porthan K, Tang A, Idilman I, et al.
JHEP Rep
. 2023 Dec;
6(1):100928.
PMID: 38089550
Background & Aims: Pathologists quantify liver steatosis as the fraction of lipid droplet-containing hepatocytes out of all hepatocytes, whereas the magnetic resonance-determined proton density fat fraction (PDFF) reflects the tissue...
9.
Eroglu I, Iremli B, Idilman I, Yuce D, Lay I, Akata D, et al.
J Clin Endocrinol Metab
. 2023 Aug;
109(1):e119-e129.
PMID: 37590020
Context: Nonalcoholic fatty liver disease (NAFLD) is a metabolical disorder and can lead to liver fibrosis. Because it is commonly seen, several noninvasive scores (NS) have been validated to identify...
10.
Idilman I, Karcaaltincaba M
Eur Radiol
. 2023 Jul;
33(12):8540-8541.
PMID: 37432404
No abstract available.